2025 brought significant regulatory and other changes to the pharmaceutical sector in Ukraine.
In a detailed market update, our Antitrust and Competition practice team summarises key developments that may impact pharma and healthcare industry actors and other stakeholders.
READ THE DIGEST
IN FOCUS:
- Notable decisions and initiatives of the Antimonopoly Committee of Ukraine
- Pharma M&A news